Trials / Conditions / Community-Acquired Infections

Community-Acquired Infections

25 registered clinical trials studyying Community-Acquired Infections — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia NCT06996834	Assiut University	N/A
Enrolling By Invitation	ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly PatientsA NCT07070284	Joan Sabater Riera	—
Recruiting	Clinical and Ecological Impact of a Primary Care Antimicrobial Stewardship Program Based on Telematic Educatio NCT06706583	Fundación Pública Andaluza para la gestión de la Investigación en Sevilla	N/A
Not Yet Recruiting	Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese Medicine NCT06613659	Henan University of Traditional Chinese Medicine	—
Recruiting	Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis NCT06103500	Ottawa Hospital Research Institute	N/A
Unknown	Community-based RSV Surveillance in Infant Mortality: Minimally Invasive Tissue Sampling Study in Karachi, Pak NCT05047549	Aga Khan University	—
Completed	Community-associated Highly-Resistant Enterobacterales NCT03924934	University of North Carolina, Chapel Hill	—
Completed	Sepsis-3 Study in Northeast Thailand NCT03379402	University of Oxford	—
Unknown	Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe Pneumonia NCT03185923	Henan University of Traditional Chinese Medicine	Phase 3
Unknown	Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis NCT03093220	Peking University People's Hospital	—
Unknown	CA-MRSA Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome NCT03064464	Sir Run Run Shaw Hospital	—
Completed	Optimization Management Study of Community Urinary Tract Infections Spectrum NCT03655548	University Hospital, Brest	—
Completed	Management of Parapneumonic Pleurisy Guided by an Early Pleural Ultrasound NCT04348734	Central Hospital Saint Quentin	—
Completed	Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13) NCT02531438	Paratek Pharmaceuticals Inc	Phase 3
Completed	Community Acquired Bacteremic Syndromes in Young Nigerian Children NCT02946775	University of Nebraska	—
Completed	Validation of Vital Signs and Symptoms for the Diagnosis of Serious Infections in Children in the Paediatric A NCT01396798	KU Leuven	—
Terminated	A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pn NCT01110421	Janssen Research & Development, LLC	Phase 3
Completed	Role of Beta-blockers in the Prevention on the Arisen of a Severe Sepsis (TESS) NCT01606631	Rennes University Hospital	—
Completed	Community-acquired Pneumonia in Buskerud County in Norway NCT01563315	Vestre Viken Hospital Trust	—
Completed	Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects NCT00575094	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates NCT00475930	Henry M. Jackson Foundation for the Advancement of Military Medicine	N/A
Completed	Tigecycline In-Vitro Surveillance Study In Taiwan NCT00488397	Wyeth is now a wholly owned subsidiary of Pfizer	—
Terminated	Helmet Continuous Positive Airway Pressure Versus Oxygen Venturi in Acute Respiratory Failure in CAP: CAPOVeRS NCT00603564	University of Milan	N/A
Completed	Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia NCT00081575	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae P NCT00035269	Pfizer	Phase 3